Pfizer at AWS re:Invent 2023

In this AWS re:Invent 2023 video, Lidia Fonseca, chief digital and technology officer at Pfizer, discusses how the company uses artificial intelligence (AI) and Amazon Web Services (AWS) to achieve the scale to treat more than 1.3 billion people with medicines and vaccines in 2022. Fonseca shows how Pfizer centralized its data, cultivated strong AI talent, and built a secure global foundation in the cloud while saving tens of millions of dollars annually. Pfizer and AWS created the Scientific Data Cloud, which aggregates data from hundreds of laboratory instruments to make it simpler and faster for scientists to search the data. On AWS, Pfizer built VOX, a generative AI solution that uses large language models from Amazon SageMaker and Amazon Bedrock, to accelerate research, predict product yield, and help it deliver more medicines to patients. 

Pfizer’s close relationship with AWS also helped it respond quickly to the COVID-19 pandemic. In the first weeks, AWS provided additional compute capacity on demand to accelerate manufacturing and clinical trials. Learn how Pfizer migrated tens of thousands of applications, databases, and servers in just a few months to transform from a company with just 10 percent of its infrastructure in the cloud into one that’s 80 percent cloud based.

Lidia Fonseca is the Chief Digital and Technology Officer at Pfizer, responsible for enterprise-wide digital, data and technology strategy and solutions to support the purpose of delivering Breakthroughs that Change Patients’ Lives. She also leads Learning and Development and Business Process Excellence. In her prior role, Lidia was CIO at Quest Diagnostics, the world’s leading provider of diagnostic information services. She earned a BA from the University of California, Berkeley and an MBA and Master Business Informatics from Rotterdam School of Management, Erasmus Graduate School of Business.